Myomo (MYO) Free Cash Flow (QoQ) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 73.30% |
| Jun 30, 2025 | -303.20% |
| Mar 31, 2025 | -206.84% |
| Dec 31, 2024 | 238.05% |
| Sep 30, 2024 | 10.83% |
| Jun 30, 2024 | 38.42% |
| Mar 31, 2024 | -38.45% |
| Dec 31, 2023 | -34.97% |
| Sep 30, 2023 | -488.66% |
| Jun 30, 2023 | 83.86% |
| Mar 31, 2023 | 24.55% |
| Dec 31, 2022 | 12.01% |
| Sep 30, 2022 | -3.84% |
| Jun 30, 2022 | -13.84% |
| Mar 31, 2022 | -28.07% |
| Dec 31, 2021 | 18.54% |
| Sep 30, 2021 | 36.66% |
| Jun 30, 2021 | -66.44% |
| Mar 31, 2021 | -87.85% |
| Dec 31, 2020 | 36.99% |
| Sep 30, 2020 | 50.14% |
| Jun 30, 2020 | -49.01% |
| Mar 31, 2020 | 7.71% |
| Dec 31, 2019 | -15.88% |
| Sep 30, 2019 | 1.01% |
| Jun 30, 2019 | 25.86% |
| Mar 31, 2019 | -23.90% |
| Dec 31, 2018 | -0.14% |
| Sep 30, 2018 | -6.66% |
| Jun 30, 2018 | -1.34% |
| Mar 31, 2018 | -45.47% |
| Dec 31, 2017 | 14.18% |
| Sep 30, 2017 | -17.69% |
| Jun 30, 2017 | -36.02% |
| Mar 31, 2017 | -29.00% |
| Dec 31, 2016 | 31.23% |